A Structured Path to Successful EUDAMED Implementation

EUDAMED registration timeframe 

Manufacturers face the challenging task to register their legacy devices and MDR/IVDR devices that received a CE mark before May 28, 2026 in EUDAMED by November 28, 2026 at the latest. From May 28, 2026, new MDR/IVDR devices may only be placed on the market after registration in EUDAMED. In order to be fit for the future, manufacturer’s processes, technology and information landscapes need to be adapted. The exact number of devices to be registered is unknown. However, there are more than 500,000 types of medical devices and in-vitro diagnostic devices on the EU market in total. The relevant data of each device and its variants qualified for EUDAMED registration need to be integrated within the set timeframe. 

Due to this large number, concerns have been raised that a bottleneck in accessing the EUDAMED database and resource availability towards the end of the transition period could prevent manufacturers from fulfilling their duty in time. Figure 1 shows the timeline of the 6-month transition period between the European Commission’s notice of the functionality of EUDAMED’s four core modules and the mandatory use of EUDAMED for new MDR/IVDR devices. Legacy devices and MDR/IVDR devices certified prior to May 28, 2026 benefit from an extended transition period for registration by manufacturers, as well as for the entry of respective certificate data by notified bodies. 

Devices that are not properly registered with EUDAMED cannot be legally distributed, sold or made available to healthcare providers in EU member states. This leads to lost sales and unmet targets, as well as incurring substantial costs associated with reintroducing the products. Non-compliant companies face severe consequences, including immediate financial penalties and suspension of their authorisation to distribute medical devices in European markets. These repercussions can have a profound impact on a company’s operational stability and pose reputational risks. 

Therefore, a well-structured implementation approach is required to maintain EU market access, achieve timely and efficient EUDAMED registration, implement scalable solutions to support growing product portfolios, optimise resource allocation, safeguard data integrity, and proactively mitigate the risk of bottlenecks.

EUDAMED readiness is the result of multi-disciplinary collaboration

The implementation of EUDAMED has considerable implications for device manufacturersacross multiple areas, including their processes, organisational structure,technology landscape, and data management. Preparing for these changes is critical toachieving compliance and supporting future readiness.

Structured approach for in-time and efficient product registration

Due to the substantial volume of data that must be integrated into the EUDAMED database by the November 28, 2026 deadline, significant system traffic is expected – especially as the deadline approaches. To avoid delays and ensure a smooth registration process, it is advisable to begin with a structured and systematic approach as for example:

A good resource to start the EUDAMED compliance journey is the EUDAMED information centre  which provides relevant information such as infographics, guidance documents for the different modules, and information on data exchange.

Starting preparations now and adhering to a structured and strategic implementation plan will not only mitigate the risks of last-minute complications, such as bottlenecks, but will also ensure compliance with EUDAMED requirements. Furthermore, this approach will help safeguard business continuity and ensure sustained access to the EU market.

Download the whitepaper here for more information.

You have questions? Speak with our experts

At Deloitte, we offer comprehensive support to device manufacturers on their EUDAMED compliance journey. We conduct readiness assessments to evaluate your readiness for EUDAMED integration. These assessments involve a thorough examination of your internal processes, organisational structure, technological infrastructure, and data and documentation practices to ensure compliance with EUDAMED requirements. 

Preparing for EUDAMED integration involves significant tasks that demand considerable time and resources. To assist with this process, we offer customized support, including guidance on a structured approach to timely and efficient product registration, practical assistance with data collection, validation, and remediation for submissions, the establishment and implementation of EUDAMED processes, Deloitte’s on-premise bulk-upload/download or M2M solution, and the development of a robust data governance framework. We can also help you to evaluate the requirements of new tools, selecting and implementing the most suitable ones for EUDAMED data management and submissions. Our ultimate goal is to help manufacturers meet EUDAMED requirements, ensuring their devices remain on the European market for the benefit of patients.